These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17531374)

  • 1. What is the optimal BCG dose in non-muscle-invasive bladder cancer?
    Witjes JA
    Eur Urol; 2007 Nov; 52(5):1300-2. PubMed ID: 17531374
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials.
    Sylvester RJ
    Eur Urol; 2008 May; 53(5):1002. PubMed ID: 17950990
    [No Abstract]   [Full Text] [Related]  

  • 3. Intravesical chemotherapy in non-muscle-invasive bladder cancer: what schedule and duration of treatment?
    Sylvester RJ
    Eur Urol; 2007 Oct; 52(4):951-3; discussion 953-4. PubMed ID: 17374437
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of BCG "Failures".
    Palou Redorta J
    Eur Urol; 2006 May; 49(5):779-80. PubMed ID: 16616207
    [No Abstract]   [Full Text] [Related]  

  • 5. [BCG therapy. Its role in the treatment of tumors of the bladder].
    Patard JJ; Chopin DK; Abbou CC
    Ann Urol (Paris); 1995; 29(5):292-3. PubMed ID: 8638911
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56.
    Aldemir M; Canda AE; Balbay MD
    Eur Urol; 2010 Aug; 58(2):e23; author reply e24-5. PubMed ID: 20542629
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of previous bacille Calmette-Guérin failure pattern on subsequent response to bacille Calmette-Guérin plus interferon intravesical therapy.
    Gallagher BL; Joudi FN; Maymí JL; O'Donnell MA
    Urology; 2008 Feb; 71(2):297-301. PubMed ID: 18308107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence over the long-term prognosis of BCG therapy and the surgical treatment in superficial bladder cancer treatment].
    Higashi S; Matsui Y; Takahashi T; Nishiyama H; Ito N; Yamamoto S; Kamoto T; Ogawa O
    Hinyokika Kiyo; 2005 Aug; 51(8):529-31. PubMed ID: 16164268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Guidelines for good practice of intravesical instillations of BCG and mitomycin C from the French national cancer committee (CC-AFU) for non-muscle invasive bladder cancer].
    Rouprêt M; Neuzillet Y; Larré S; Pignot G; Coloby P; Rébillard X; Mongiat-Artus P; Chartier-Kastler E; Soulié M; Pfister C;
    Prog Urol; 2012 Nov; 22(15):920-31. PubMed ID: 23102014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chemosensitivity test to individualize intravesical treatment for non-muscle-invasive bladder cancer.
    Gazzaniga P; Gradilone A; de Berardinis E; Sciarra A; Cristini C; Naso G; di Silverio F; Frati L; Aglianò AM
    BJU Int; 2009 Jul; 104(2):184-8. PubMed ID: 19154503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [ BCG-immunotherapy and bladder cancer].
    Rischmann P
    Prog Urol; 2008 May; 18 Suppl 5():S93. PubMed ID: 18585633
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intravesical instillation for bladder tumors].
    Rivière A; Ploussard G; Desgranchamps F
    Rev Prat; 2014 Dec; 64(10):1388-9. PubMed ID: 25665319
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment on: Long-term intravesical adjuvant chemotherapy further reduces recurrence rate compared with short-term intravesical chemotherapy and short-term therapy with Bacillus Calmette-Guérin (BCG) in patients with non-muscle-invasive bladder cancer.
    Evans CP
    Eur Urol; 2007 Oct; 52(4):1129-30. PubMed ID: 17383082
    [No Abstract]   [Full Text] [Related]  

  • 14. BCG installations for bladder cancer and latent tuberculosis infection.
    Hanson K
    Urol Nurs; 2002 Apr; 22(2):132-4. PubMed ID: 11993243
    [No Abstract]   [Full Text] [Related]  

  • 15. Is the role of intravesical bacillus Calmette-Guérin in non-muscle-invasive bladder cancer changing?
    Ayres BE; Griffiths TR; Persad RA
    BJU Int; 2010 Feb; 105 Suppl 2():8-13. PubMed ID: 20089092
    [No Abstract]   [Full Text] [Related]  

  • 16. Is intravesical bacillus Calmette-Guérin better than mitomycin for intermediate-risk bladder cancer?
    Dalbagni G
    Eur Urol; 2009 Aug; 56(2):257-8; discussion 258-9. PubMed ID: 19427109
    [No Abstract]   [Full Text] [Related]  

  • 17. [Intravesical therapy: Influence on superficial bladder cancer progression].
    García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; Alvarez Múgica M; Rodríguez Robles L; Martín Benito JL; San Martín Blanco A; Regadera Sejas J
    Arch Esp Urol; 2007; 60(1):31-5. PubMed ID: 17408169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of non-muscle invasive bladder tumours by instillations of mitomycin C and BCG: a survey on French urologists by the French Urological Association].
    Descazeaud A; Mignard JP; Davin JL; Irani J
    Prog Urol; 2009 Oct; 19(9):624-31. PubMed ID: 19800553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Per-Uno Malmström, Richard J. Sylvester, David E. Crawford, et al. An individual patient data meta-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus Calmette-Guérin for non-muscle-invasive bladder cancer. Eur Urol 2009;56:247-56.
    Lamm D; Böhle A; Palou J; Persad R; Brausi M; Colombel M; Akaza H; Buckley R
    Eur Urol; 2010 Feb; 57(2):e7-9; author reply e10-1. PubMed ID: 19914768
    [No Abstract]   [Full Text] [Related]  

  • 20. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
    García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; González Alvarez RC; Jalón Monzón A; Martínez Gómez FJ; Sánchez Trilla A; Regadera Sejas J
    Arch Esp Urol; 2007; 60(1):36-43. PubMed ID: 17408170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.